Skip to main content

HbA1c Stability Tied to Lower Risk for Alzheimer Disease and Related Dementias

By Lori Solomon HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on Aug 8, 2024.

via HealthDay

THURSDAY, Aug. 8, 2024 -- Increased glycated hemoglobin (HbA1c) stability within patient-specific target ranges is associated with a lower risk for Alzheimer disease and related dementias (ADRD), according to a study published online Aug. 2 in JAMA Network Open.

Patricia C. Underwood, Ph.D., from the William F. Connell School of Nursing at Boston College, and colleagues examined the association between HbA1c time in range (TIR) and the incidence of ADRD in older veterans with diabetes. The analysis included 374,021 veterans with diabetes identified from administrative health care data (2005 to 2014) and followed for up to 10 years.

The researchers found that lower HbA1c TIR was associated with an increased risk for incident ADRD (HbA1c TIR of 0 to <20 percent versus ≥80 percent: hazard ratio, 1.193). The direction of out-of-range HbA1c levels was also associated with incident ADRD. Having greater time below range was associated with a significantly increased risk (hazard ratio, 1.23). When excluding individuals with baseline use of medications associated with hypoglycemia risk (e.g., insulin and sulfonylureas) or hypoglycemia events, findings remained significant.

"These results affirm the benefits of applying personalized HbA1c target ranges based on age, life expectancy, and comorbidities," the authors write. "Clinicians should work with patients to ensure HbA1c stability to reduce ADRD risk in older adults with diabetes."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Lower Risk of Alzheimer Disease Seen for Breast Cancer Survivors

MONDAY, June 30, 2025 -- Breast cancer survivors have a lower risk of Alzheimer disease (AD) compared with cancer-free controls, according to a study published online June 20 in...

Late-Life Mood Disorders May Indicate Predisposition to Dementia

MONDAY, June 30, 2025 -- Alzheimer disease (AD) and diverse non-AD tau pathologies may contribute to late-life mood disorders (LLMDs), according to a study published online June 9...

Muscle Ultrasound Can Detect Insulin Resistance

MONDAY, June 30, 2025 -- Muscle ultrasound can detect insulin resistance and lower muscle mass, according to a study published online June 12 in the Journal of Ultrasound...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.